First Patient Takes Part in New Phase I Clinical Trial for Patients with Recurrent Glioblastoma

Paul Read is the first patient to be recruited to a new clinical trial that has opened at University College London Hospitals NHS Foundation Trust (UCLH). Scans revealed a 50 per cent reduction in his tumor at the end of treatment.